Press release
Familial Adenomatous Polyposis Treatment Market Will Generate Record Revenue by 2028
According to the National Organization for Rare Disorders (NORD), FAP affects males and females equally and occurs in approximately one in 5,000 to 10,000 individuals in the US. Additionally, it accounts for about 0.5% of all cases of colorectal cancer. Furthermore, it is estimated that it affects almost 50,000 American families. Moreover, as per the American Society of Clinical Oncology (ASCO), it is estimated that most people with FAP will have multiple colon polyps by age 35 and approximately 30% of people with FAP do not have any family history of the condition. Further, it is estimated that people affected with FAP have a 100% risk of colorectal cancer if polyps are not removed. Hence, the rising prevalence of the disease is driving the demand for familial adenomatous polyposis treatment.
To Request a Sample of our Report on Familial Adenomatous Polyposis Treatment Market: https://www.omrglobal.com/request-sample/familial-adenomatous-polyposis-treatment-market
Some major players operating in the market include Cancer Prevention Pharmaceuticals Inc, Marina Biotech, Inc, and Thetis Pharmaceuticals LLC, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Cancer Prevention Pharmaceuticals, Inc. announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA). It was aimed to receive accelerated approval for CPP-1X/sul for the treatment of adults with familial adenomatous polyposis (FAP).
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Cancer Prevention Pharmaceuticals Inc, Marina Biotech Inc, and Thetis Pharmaceuticals LLC, among others.
Familial Adenomatous Polyposis Treatment Market Report by Segment
By Type
Icosapent
Eflornithine Hydrochloride
Aspirin
CEQ-508
Others
By Application
Hospital
Clinics
Others
A full Report of Familial Adenomatous Polyposis Treatment Market is Available @ https://www.omrglobal.com/industry-reports/familial-adenomatous-polyposis-treatment-market
Familial Adenomatous Polyposis Treatment Market Report by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East & Africa
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
https://sportmsr.com/%d8%b3%d9%88%d9%82-%d8%b9%d9%84%d8%a7%d8%ac-%d8%a3%d9%85%d8%b1%d8%a7%d8%b6-%d8%a7%d9%84%d9%83%d9%84%d9%89-%d9%81%d9%8a-%d8%a7%d9%84%d9%85%d8%b1%d8%ad%d9%84%d8%a9-%d8%a7%d9%84%d9%86%d9%87%d8%a7%d8%a6/
https://revistaeconomiasocial.com/2022/12/23/el-mercado-del-sistema-de-recoleccion-de-energia-sera-testigo-de-la-aceleracion-del-crecimiento-para-2028/
https://citytoday-hildesheim.de/index.php/2022/12/23/energy-harvesting-system-markt-weltweite-branchenanalyse-zukunftige-nachfrage-und-prognose-bis-2028/
https://www.asiatimeskorea.com/news/2028%eb%85%84%ea%b9%8c%ec%a7%80-%ec%97%84%ec%b2%ad%eb%82%9c-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%b3%b4%ec%9d%bc-%ed%94%84%eb%9e%91%ec%8a%a4-%ed%99%94%ec%9e%a5%ed%92%88-%ed%8f%ac%ec%9e%a5-%ec%8b%9c%ec%9e%a5/199109/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Familial Adenomatous Polyposis Treatment Market Will Generate Record Revenue by 2028 here
News-ID: 2861733 • Views: 317
More Releases from Orion Market Research
North American 3D Cell Culture Market Trends, Segmentation, Growth, Analysis and …
The North American 3D cell culture market is expected to witness a significant growth with the CAGR of 13.3% during the forecast period. The North American market for 3D cell culture is a significant market and is analyzed on the basis of the country such as the US and Canada. North American 3D Cell Culture Market reports provides us with a complete outlook on thorough assessment of thorough data about…
European Diagnostic Biomarker Market Share, Trends, Future Outlook, Analysis and …
The European diagnostic biomarker market is estimated to grow significantly at a CAGR of more than 11% during the forecast period. Factors that are contributing significantly in the market growth include the presence of a well-developed healthcare sector and considerably high healthcare expenditure and infrastructure in its economies such as Germany, UK, France and many more. European Diagnostic Biomarker Market reports provides us with a complete outlook on thorough assessment…
European Biological Sample Handling Market Size, Share, Growth, Analysis and For …
The European biological sample handling market is forecast to grow at a CAGR of around 8.4% during the forecast period. Europe is expected to share significantly in the global biological sample handling market owing to the well-developed healthcare sector, and significant research in the field of geniomics and protecomics in its economies such as UK, Germany, Italy, Spain and many more. European Biological Sample Handling Market reports provides us with…
Asia-Pacific Biological Sample Handling Market Size, Share, Growth, Analysis and …
Asia-Pacific Biological Sample Handling market is expected to grow at CAGR of around 9.3% during the forecast period. Asia-Pacific is estimated to be a potential market for biological sample handling due to the increasing R&D and investments by government organizations in life science research. Asia-Pacific Biological Sample Handling Market reports provides us with a complete outlook on thorough assessment of thorough data about vital feature of the global industry related…
More Releases for Familial
Familial Adenomatous Polyposis (FAP) Therapeutics- Pipeline Analysis 2018
Familial adenomatous polyposis (FAP) is a genetic disorder, characterized by the development of adenomatous colon polyps in the intestinal tract, resulting in colon cancer. The disease is diagnosed when more than 100 adenomatous colon polyps are developed in a person.
Download the sample report at: https://www.pharmaproff.com/request-sample/1025
A person with FAP is at a high risk of developing cancer of small intestines or stomach. This disease is categorized into three types including attenuated…
Familial Amyloid Cardiomyopathy Treatment Market Opportunity Analysis, 2018–20 …
Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy is also known as hereditary cardiac transthyretin amyloidosis or hereditary amyloid cardiomyopathy. The protein transthyretin amyloid fibrils infiltrate the myocardium that leads to diastolic dysfunction from restrictive cardiomyopathy, which eventually result to heart failure. There are several mutation in TTR which are associated…
Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2017
Market Research Hub's latest Pharmaceutical and Healthcare disease pipeline guide “Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review”, H2 2017, provides an overview of the Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorders) pipeline landscape.
Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder caused due to a mutation (alteration) of FH from one (affected) parent. Symptoms include xanthesmas, corneal arcus, aortic rupture and peripheral vascular disease. Risk factors include age, sex, smoking and hypertension,…
Familial Adenomatous Polyposis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Familial Adenomatous Polyposis - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous Polyposis - Pipeline Review, H2 2017, provides an overview of the Familial Adenomatous Polyposis (Genetic Disorders) pipeline landscape.
Familial adenomatous polyposis (FAP) or classic FAP is a genetic condition that causes extra…
Familial Chylomicronemia Syndrome Treatment Market
Familial Chylomicronemia Syndrome is a genetic condition characterized by an inability of the body to digest fats mainly triglyceride. In Familial Chylomicronemia Syndrome, the lipoprotein lipase (LPS) is not functional, which is the enzyme that breaks down chylomicrons in the blood. The most distinctive sign of Familial Chylomicronemia Syndrome is the appearance of fatty blood on the skin, mainly owing to high level of fat in the body. People with…
Familial Adenomatous Polyposis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Familial Adenomatous Polyposis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous Polyposis - Pipeline Review, H1 2017, provides an overview of the Familial Adenomatous Polyposis (Genetic Disorders) pipeline landscape.
Familial adenomatous polyposis (FAP) is also known as familial polyposis coli, adenomatous polyposis coli, or…
